Treatment of Crohn's Disease With Infliximab and Subsequent Development of Takayasu's Arteritis

被引：0

作者：

Nomura, Kei ^{[1
]}

Shibuya, Tomoyoshi ^{[1
,2
]}

Furusho, Momoko ^{[1
]}

Ishino, Hirotaka ^{[1
]}

Orikasa, Masayuki ^{[1
]}

Omori, Masashi ^{[1
]}

Odakura, Rina ^{[1
]}

Koma, Masao ^{[1
]}

Ito, Kentaro ^{[1
]}

Maruyama, Takafumi ^{[1
]}

Ishikawa, Dai ^{[1
,2
]}

Hojo, Mariko ^{[1
,2
]}

Nagahara, Akihito ^{[1
,2
]}

机构：

[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan

[2] Juntendo Univ, Sch Med, Dept Pathophysiol Res & Therapeut Gastrointestinal, Bunkyo Ku, Tokyo 1138421, Japan

来源：

GASTROENTEROLOGY RESEARCH | 2024年 / 17卷 / 5-6期

关键词：

Crohn's disease; Infliximab; Prednisolone; Takayasu's arteritis; INFLAMMATORY-BOWEL-DISEASE; ASSOCIATION; AORTITIS; PATIENT; CLASSIFICATION; MECHANISMS; VASCULITIS; CRITERIA;

D O I：

10.14740/gr1792

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

A 23-year-old man was diagnosed with Crohn's disease (CD) of the large intestine after colonoscopy revealed longitudinal ulcers, and pathology revealed non-caseating epithelioid cell granulomas and anal fistulas. The CD relapsed, and therefore prednisolone (PSL) and infliximab (IFX) treatment was initiated. The PSL was gradually tapered. Steroid-free remission was maintained with IFX. The patient subsequently developed a high fever and headache, while CD-related symptoms did not worsen. Laboratory data showed white blood cells at 14,200/mu L and C-reactive protein at 17.2 mg/ dL. Contrast-enhanced computed tomography revealed thoracoabdominal aortitis, and the patient was consequently diagnosed with ment that immediately reduced the fever and headache. The PSL to maintain CD remission. No further episodes of aortitis relapse were noted after restarting IFX, and the CD currently remains in investigate the possibility of vasculitis.

引用

页码：217 / 223

页数：7

共 50 条

[41] Treatment of pulmonary Crohn's disease with infliximab
See, MC
Venkataraman, P
Newman, LJ
Berezin, SH
Medow, CM
Halata, MS
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S296 - S296
[42] Treatment of oesophageal Crohn's disease by infliximab
Filippi, J
Mambrini, P
Arab, K
Schneider, SM
Hébuterne, X
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (01): : 84 - 85
[43] Treatment of oesophageal Crohn's disease with infliximab
Theodoropoulou, A
Koutroubakis, LE
Kouroumalis, EA
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (04) : 431 - 432
[44] Remicade (infliximab) for the treatment of Crohn's disease
Brazier, F
Delcenserie, R
Dupas, JL
PRESSE MEDICALE, 2000, 29 (26): : 1463 - 1464
[45] Treatment of fistulas in Crohn's disease with infliximab
Löfberg, R
GUT, 1999, 45 (05) : 642 - 643
[46] Clinically silent Crohn's disease in a patient with Takayasu's Arteritis unresponsive to conventional therapies
Yilmaz, Neslihan
Can, Meryem
Alibaz-Oner, Fatma
Direskeneli, Haner
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 3091 - 3093
[47] Clinically silent Crohn’s disease in a patient with Takayasu’s Arteritis unresponsive to conventional therapies
Neslihan Yilmaz
Meryem Can
Fatma Alibaz-Oner
Haner Direskeneli
Rheumatology International, 2013, 33 : 3091 - 3093
[48] Takayasu's arteritis and Crohn's disease: an unusual association. Report on two cases
Biagi, P
Castro, R
Campanella, G
Parisi, G
Gobbini, AR
Vedovini, G
DIGESTIVE AND LIVER DISEASE, 2001, 33 (06) : 487 - 491
[49] Unveiling the Overlap: Takayasu Arteritis Manifestation in an Adult Patient With Crohn's Disease
Abbasi, Abu Fahad
Trikantzopoulou, Filippa
Amalraj, Joshua
Patel, Krishna
Naik, Amar
Abegunde, Ayokunle T.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2168 - S2169
[50] THE DISEASE ASSOCIATIONS OF TAKAYASU'S ARTERITIS
Esatoglu, S. N.
Celik, A. M.
Ucar, D.
Celik, A. F.
Ugurlu, S.
Hatemi, G.
Melikoglu, M.
Fresko, I.
Hamuryudan, V.
Ozdogan, H.
Yurdakul, S.
Yazici, H.
Seyahi, E.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1100 - 1101

← 1 2 3 4 5 →